Wednesday, March 28, 2018

On the Record


"The 'malintent' is overplayed, but PBMs I think would be better off just complying and backing away from [gag clauses], just because it doesn't look good."

— Jay Godla, a partner at PwC's Strategy&, tells Radar on Drug Benefits about PBMs' so-called "gag clauses," which bar pharmacists from telling customers if they would pay less if they did not use insurance.

No comments:

Post a Comment